Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025;17(1):102-112.
doi: 10.2174/0125899775280160240122065607.

Modulation of Angiotensin-II and Angiotensin 1-7 Levels Influences Cardiac Function in Myocardial Ischemia-reperfusion Injury

Prabhat Kumar Upadhyay  1 , Navneet Thakur  2 , Vishal Kumar Vishwakarma  2 , Hridaya Shankar Chaurasiya  3 , Tarique Mahmood Ansari  4
Affiliations
Review

Modulation of Angiotensin-II and Angiotensin 1-7 Levels Influences Cardiac Function in Myocardial Ischemia-reperfusion Injury

Prabhat Kumar Upadhyay et al. Curr Drug Res Rev. 2025.

Abstract

The angiotensin-converting enzyme-2 (ACE-2) alters the pathophysiology of various fatal cardiovascular diseases, including ischemic heart disease, whereas angiotensin 1-7 (Ang 1-7) exerts a wide range of actions. The effects of ischemia-reperfusion (IR) injury include damage to myocardial tissue that initiates protease action, causing cardiac cell death. Angiotensin- II (Ang-II) contributes through the renin-angiotensin system (RAS) to the IR injury, whereas Ang 1-7 paradoxically exerts a protective effect through the same. Thus, the myocardial ischemic reperfusion injury (MIRI) may be altered by the RAS of the heart. This review paper focuses on ACE-2, angiotensin-converting enzyme (ACE), and Ang 1-7 regulation in the RAS of the heart in the pathophysiology of MIRI. The treatment in such conditions using ACE-2 activator, ACE inhibitor, and Ang-II antagonists may promote vascular functions as well as cardio- protection.

Keywords: ACE inhibitor; ACE-2 activator; Heart; angiotensin-II antagonist.; myocardial ischemia-reperfusion injury; renin-angiotensin system.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Sreeniwas Kumar A.; Sinha N.; Cardiovascular disease in India: A 360 degree overview. Med J Armed Forces India 2020,76(1),1-3 - DOI - PubMed
    1. Nag T.; Ghosh A.; Cardiovascular disease risk factors in Asian Indian population: A systematic review. J Cardiovasc Dis Res 2013,4(4),222-228 - PubMed
    1. Kontos M.C.; Diercks D.B.; Kirk J.D.; Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc 2010,85(3),284-299 - DOI - PubMed
    1. Goyal A.; Agrawal N.; Ischemic preconditioning: Interruption of various disorders. J Saudi Heart Assoc 2017,29(2),116-127 - DOI - PubMed
    1. Ferdinandy P.; Hausenloy D.J.; Heusch G.; Baxter G.F.; Schulz R.; Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 2014,66(4),1142-1174 - DOI - PubMed

MeSH terms

LinkOut - more resources